Anna Kruczynski Selected Research

Anna Kruczynski Research Topics

Disease

23	Neoplasms (Cancer) 07/2016 - 01/2002
4	Neuroblastoma 10/2014 - 09/2004
3	Colonic Neoplasms (Colon Cancer) 08/2015 - 02/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 12/2011
3	Glioblastoma (Glioblastoma Multiforme) 12/2014 - 06/2009
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2012 - 06/2009
3	Leukemia 01/2012 - 05/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 11/2006
2	Lymphoma (Lymphomas) 11/2012 - 05/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2011 - 07/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2010 - 06/2009
1	Ovarian Epithelial Carcinoma 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 08/2015
1	Papillary Thyroid Cancer 08/2015
1	Poisoning 10/2014
1	Glioma (Gliomas) 10/2014
1	Genetic Translocation (Chromosomal Translocation) 11/2012
1	Carcinoma (Carcinomatosis) 11/2012
1	Carcinogenesis 11/2012
1	Disease Progression 01/2012
1	Skin Diseases (Skin Disease) 05/2010
1	Rhabdomyosarcoma 06/2009
1	Lung Neoplasms (Lung Cancer) 06/2009
1	Breast Neoplasms (Breast Cancer) 12/2008
1	Leukemia L1210 12/2008
1	Leukemia P388 08/2008
1	Neoplasm Metastasis (Metastasis) 11/2006
1	Xeroderma Pigmentosum (Kaposi's Disease) 05/2004

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2014 - 05/2004
7	Pharmaceutical PreparationsIBA 07/2016 - 09/2004
5	F14512IBA 01/2016 - 12/2008
5	PolyaminesIBA 01/2016 - 12/2008
5	vinflunineIBA 01/2013 - 09/2004
4	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2016 - 12/2008
4	Vinca AlkaloidsIBA 12/2014 - 01/2002
4	SpermineIBA 10/2014 - 12/2008
3	Etoposide (VP 16)FDA LinkGeneric 01/2016 - 12/2011
3	Phosphotransferases (Kinase)IBA 08/2015 - 09/2004
3	Anaplastic Lymphoma KinaseIBA 11/2012 - 06/2009
3	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 02/2002
3	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2008 - 09/2004
2	TropomyosinIBA 08/2015 - 05/2010
2	AntibodiesIBA 01/2013 - 01/2012
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2012 - 02/2011
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 12/2008
2	UbiquitinIBA 08/2008 - 02/2007
2	Vinorelbine (Navelbine)FDA LinkGeneric 08/2008 - 01/2002
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	PlatinumIBA 01/2016
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 08/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015
1	cryptopleurineIBA 01/2015
1	AlkaloidsIBA 12/2014
1	Topoisomerase II InhibitorsIBA 10/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2012
1	Monoclonal AntibodiesIBA 01/2012
1	Alexa Fluor 750IBA 01/2012
1	PoisonsIBA 12/2011
1	Podophyllotoxin (Condylox)FDA LinkGeneric 12/2011
1	DNA Methyltransferase 3AIBA 11/2011
1	MicroRNAs (MicroRNA)IBA 06/2011
1	Doxycycline (Periostat)FDA LinkGeneric 05/2010
1	Tyrosine (L-Tyrosine)FDA Link 05/2010
1	Polo-Like Kinase 1IBA 07/2009
1	F 91874IBA 06/2009
1	SpermidineIBA 12/2008
1	PutrescineIBA 12/2008
1	LuciferasesIBA 08/2008
1	TubulinIBA 11/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2006
1	DNA TopoisomerasesIBA 09/2004
1	Growth Factor ReceptorsIBA 09/2004
1	EndonucleasesIBA 05/2004
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2002
1	Vindesine (Vindesin)IBA 01/2002
1	Vincristine (Oncovin)FDA LinkGeneric 01/2002

Therapy/Procedure

6	Therapeutics 01/2016 - 02/2002
3	Drug Therapy (Chemotherapy) 12/2014 - 01/2002